1,055 filings
Page 34 of 53
DEF 14A
ORKA
Oruka Therapeutics Inc.
Definitive proxy
30 Mar 11
12:00am
DEFA14A
ORKA
Oruka Therapeutics Inc.
30 Mar 11
Additional proxy soliciting materials
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
28 Mar 11
Departure of Directors or Certain Officers
12:00am
UPLOAD
ORKA
Oruka Therapeutics Inc.
11 Mar 11
Letter from SEC
12:00am
10-K
2010 FY
ORKA
Oruka Therapeutics Inc.
Annual report
9 Mar 11
12:00am
S-3
ORKA
Oruka Therapeutics Inc.
Shelf registration
9 Mar 11
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
3 Mar 11
Other Events
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
17 Feb 11
Departure of Directors or Certain Officers
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
26 Jan 11
Entry into a Material Definitive Agreement
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
18 Jan 11
Other Events
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
22 Dec 10
Entry into a Material Definitive Agreement
12:00am
UPLOAD
ORKA
Oruka Therapeutics Inc.
22 Dec 10
Letter from SEC
12:00am
CORRESP
ORKA
Oruka Therapeutics Inc.
21 Dec 10
Correspondence with SEC
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
14 Dec 10
Entry into a Material Definitive Agreement
12:00am
UPLOAD
ORKA
Oruka Therapeutics Inc.
10 Dec 10
Letter from SEC
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
23 Nov 10
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
10-Q
2010 Q3
ORKA
Oruka Therapeutics Inc.
Quarterly report
15 Nov 10
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
4 Nov 10
Arca Biopharma Awarded $489,000 Grant Under Qualifying
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
7 Oct 10
Arca Biopharma Announces European Patent Issued for Treating
12:00am
CT ORDER
ORKA
Oruka Therapeutics Inc.
7 Sep 10
Confidential treatment order
12:00am